Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
30 Oct 2024
Penicillin Reduces the Risk of Parkinson’s Disease
Individuals who received multiple courses of penicillin antibiotics had a 15% lower risk of developing Parkinson’s disease (PD), while those who used antifungal medications had a 16% higher risk.
30 Oct 2024
Dual Bronchodilator Therapy Shows Promise for COPD Smokers
A new study has shown that dual bronchodilator therapy can help reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), with notable differences in efficacy between current and former smokers.
30 Oct 2024
Teleprehabilitation Effective for Reducing Adverse Events After Cardiac Surgery
A RECENT study found that multimodal, personalised teleprehabilitation significantly reduced major adverse cardiovascular events (MACE) in patients undergoing elective cardiac surgery.
30 Oct 2024
SGLT2 Inhibitors More Effective in Reducing Kidney Complications
A real-world study has found that SGLT2 inhibitors and GLP-1 receptor agonists are more effective at reducing kidney complications in adults with Type 2 diabetes and moderate cardiovascular risk compared to DPP-4 inhibitors and sulfonylureas.
30 Oct 2024
Low FOXP3+ Cell Count Linked to Poor Outcomes in Rare T Cell Lymphoma
Low levels of FOXP3+ regulatory T cells are associated with worse progression-free survival and more aggressive disease characteristics in patients with angioimmunoblastic T cell lymphoma.
30 Oct 2024
Resiliency Against Air Pollution
The discussion-based symposium video on climate change and air pollution emphasised the urgency for heightened awareness and action…
30 Oct 2024
Hema Now: Episode 3: Reflections on the EHA Congress
In this episode of Hema Now, Dr. Jonathan Sackier welcomes Professor Antonio Almeida, a leader in hematology and the 2024 President of the EHA.
29 Oct 2024
New Neural Chip Developed to Induce Motor Responses
Researchers have developed an innovative 8-channel neural stimulation chip that addresses critical limitations in current devices, which often face challenges in balancing high voltage requirements and tissue safety.
29 Oct 2024
Does Standing for Longer Improve Heart Health?
New research has demonstrated that stationary behaviour, specifically prolonged sitting, is associated with increased risk of cardiovascular disease (CVD) and orthostatic circulatory disease.
29 Oct 2024
Autoimmune Diseases Linked to Premature Ovarian Insufficiency Risk
New research has shown that women with premature ovarian insufficiency (POI) have more than double the prevalence of severe autoimmune diseases compared to the general female population.
←
1
2
3
…
25
26
27
28
29
30
31
…
920
921
922
→